Stricter regulations and various requirements in pharma ensure that the industry is ever-evolving and moving forward. From improving the quality process, reducing costs and remarkable progress in R&D, now is the optimal time to look at the transparency deficiencies in the pharma sector. In which areas do you think increased transparency would be most welcome? [...]
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money. There have been some issues however with the outsourcing [...]
Researchers at the University of Cincinnati (UC) have identified a new genetic target for diuretic therapy in patients with fluid overload – like those with congestive heart failure, liver cirrhosis or kidney failure. These results, presented in the July 30 advance online edition of the journal Proceedings of the National Academy of Sciences (PNAS), may [...]
If doctors want to develop a strong rapport with parents of overweight children, it would be best if physicians used terms like “large” or “gaining too much weight” as opposed to the term “obese.” These were findings recently published by medical researchers at the University of Alberta. Geoff Ball, a researcher in the Faculty of [...]
As liver cancer develops, tumor cells lose the ability to produce and release glucose into the bloodstream, a key function of healthy liver cells for maintaining needed blood-sugar levels. The findings come from a study by scientists at The Ohio State Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research [...]
